Value of Low-Density Lipoprotein Particle Number and Size as Predictors of Coronary Artery Disease in Apparently Healthy Men and Women

El Harchaoui, Karim, van der Steeg, Wim A., Stroes, Erik S.G., Kuivenhoven, Jan Albert, Otvos, James D., Wareham, Nicholas J., Hutten, Barbara A., Kastelein, John J.P., Khaw, Kay-Tee, Boekholdt, S. Matthijs·2007·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2006.09.043

Cited by (239)

Items 201–239 of 239

  1. Therapy with noninvasive ventilation in patients with obstructive sleep apnoea: Effects on atherogenic lipoprotein phenotype
    Ružena Tkáčová, Manfredi Rizzo, Kaspar K. Berneis · 2009 · Medical Hypotheses
  2. Monitor the lipid profile
    Thomas D. Dayspring, Alan Helmbold · 2008
  3. Utility of Advanced Lipoprotein Testing in Clinical Practice
    Kenneth R. Feingold, Carl Grünfeld · 2016 · Europe PMC (PubMed Central)
  4. Non-High-Density Lipoproteins Cholesterol and Cardio-Metabolic Risk.
    Dana Emilia Bâibâță, G Ionescu, Bileana Petcov, Silvia Mancaş · 2015 · Europe PMC (PubMed Central)
  5. Quel bilan lipidique et comment l’interpréter chez le patient ayant une maladie coronaire ?
    Michel Farnier · 2009 · La Presse Médicale
  6. Concordancia entre la determinación de triglicéridos en sangre capilar y por el método tradicional
    Ana Alegría Barrero, Alberto Cordero, José Moreno Arribas, Moisés Rodríguez‐Mañero, Eduardo Alegría Ezquerra · 2009 · Medicina Clínica
  7. Effects of niacin on LDL particle number
    Haseeb Jafri, Richard H. Karas, Jeffrey T. Kuvin · 2009 · Clinical Lipidology
  8. Cholesterol: Concentration, Ratio, and Particle Number
    Ngoc‐Anh Le, Peter W.F. Wilson · 2009 · Elsevier eBooks
  9. Lipoprotein Subfractions and Particle Size in End-Stage Renal Disease
    Peter Andrew McCullough, Fawaz Al-Ejel, Robert C. Maynard · 2011 · Clinical Journal of the American Society of Nephrology
  10. Oxidative Modification of Lipoproteins: A Potential Role of Oxidized Small dense LDL in Enhanced Atherogenicity
    Mohammed Alsaweed · 2021 · Journal of Pharmaceutical Research International
  11. The benefits of measuring the size and number of lipoprotein particles for cardiovascular risk prediction: A systematic review and meta-analysis
    José A. Quesada, Vicente Bertomeu‐González, Domingo Orozco‐Beltrán, Alberto Cordero, Vicente Francisco Gil-Guillén, Adriana López‐Pineda, Rauf Nouni-García, Concepción Carratalá‐Munuera · 2023 · Clínica e Investigación en Arteriosclerosis (English Edition)
  12. Non-high-density lipoprotein cholesterol outperforms low-density lipoprotein cholesterol in predicting cardiovascular events among high-risk Asians
    Worapaka Manosroi, Phichayut Phinyo, Mattabhorn Phimphilai, Pisit Hutayanon, Siriluck Gunaparn, Arintaya Phrommintikul, Wanwarang Wongcharoen · 2025 · Journal of clinical lipidology
  13. Management of Moderate Hypertriglyceridemia in Childhood and Adolescence
    Rae-Ellen Webb Kavey · 2016 · Current Cardiovascular Risk Reports
  14. Association of a cholesteryl ester transfer protein variant (rs1800777) with fat mass, HDL cholesterol levels, and metabolic syndrome
    Daniel Antonio de Luis, Olatz Izaola, David Primo, Emilia Gómez Hoyos, Juan José López Gómez, Ana Ortolá, R. Aller · 2018 · Endocrinología Diabetes y Nutrición (English ed )
  15. Lipid lowering in the patients with prediabetes/metabolic syndrome: what is the evidence?
    George A. Steiner · 2008 · Current Opinion in Lipidology
  16. The case against ApoB and the ApoB:ApoA-I ratio: are they right?
    Allan D. Sniderman · 2008 · Future Lipidology
  17. Effect of Nonlinear Blood Viscosity on LDL Transport and Fluid-Structure Interaction Biomechanics of a Multi-stenosis Left Circumflex Coronary Artery
    Harry J. Carpenter, Mergen H. Ghayesh, Anthony C. Zander, Peter James Psaltis · 2022 · NODYCON conference proceedings series
  18. Effect of consumption of anthocyanin-rich products on NMR lipoprotein subclasses and biomarkers in hypercholesterolemic subjects: a randomized controlled trial (the AppleCOR study)
    A. Pedret, Elisabet Llauradó, Lorena Calderón-Pérez, J. Companys, Laura Pla‐Pagà, Patricia Salamanca-Gonzalez, Berner Andrée Sandoval-Ramírez, Maria Besora‐Moreno, Úrsula Catalán, Sara Fernández‐Castillejo et al. · 2025 · Food & Function
  19. Obesity alters VLDL profile and remnant cholesterol differently in metabolically healthy men and women: a ¹H-NMR study
    Victoria de Santisteban Villaplana, Anallely López‐Yerena, Natàlia Muñoz‐García, Gemma Vilahur, Lina Badimón, Teresa Padró · 2025 · Lipids in Health and Disease
  20. Transitioning from population to individualized preventive cardiology
    Morris, Wright · 2013 · Research Reports in Clinical Cardiology
  21. Lack of Association Between Low Density Lipoprotein Particle Size and On-Treatment Platelet Reactivity in Patients With Coronary Artery Disease
    Do‐Yoon Kang, Han‐Mo Yang, Kyung Woo Park, So‐Ryoung Lee, Min‐Ho Lee, Dong-Won Lee, Hae‐Young Lee, Hyun‐Jae Kang, Bon‐Kwon Koo, In‐Ho Chae et al. · 2012 · Korean Circulation Journal
  22. Clinical utility of low-density lipoprotein particle measurement in management of cardiovascular disease: a case report
    Tara Dall, Pourfarzib · 2011 · Research Reports in Clinical Cardiology
  23. Plasma Levels of Coronary Risk Biomarkers in Chronic Kidney Disease Patients Undergoing Maintenance Hemodialysis
    Takeshi Kanda, Hirobumi Tokuyama, Shu Wakino, Koichi Koichi, Hiroshi Itoh, Shingo Hori · 2014
  24. ACCF/AHA Practice Guideline
    Clyde W. Yancy, Mariell L Jessup, Biykem Bozkurt, Javed Butler, Mark H. Drazner, Gregg C. Fonarow, Stephen A. Geraci, Tamara B. Horwich, James L. Januzzi, Maryl R. Johnson et al. · 2013
  25. Effects of Enhance External Counterpulsation and Cardiac Rehabilitation on Clinical Parameters and Plasma Nitric Oxide, Endothelin1 and High Sensitive CRP in Patients with Coronary Artery Disease
    Seyed Kazem Shakouri, Fariba Eslamian, Samad Ghafari, Homayoon Sadegi, Z Kafaei Razavi, Akbar Darbin · 2014 · Medical Journal of Tabriz University of Medical Sciences and Health Services
  26. Integrative Treatments to Reduce Risk for Cardiovascular Disease.
    Ryan D. Bradley, Erica B. Oberg · 2009 · PubMed
  27. Highlights of the Year in JACC 2007
    Anthony Nicholas DeMaria, Jeroen Joost Bax, Ori Ben‐Yehuda, Paul Clopton, Gregory K. Feld, Geoffrey S. Ginsburg, Barry Greenberg, James D. Knoke, Wilbur Y.W. Lew, João A.C. Lima et al. · 2008 · Journal of the American College of Cardiology
  28. Triglycerides effect on the levels of low density lipoprotein and high density lipoprotein in type 2 diabetic patients.
    Ahmed Aubed Sherhan, Abdulhussen Omran · 2017 · The Medical Journal of Basrah University
  29. Effect of Low Fat and Low Cholesterol Diet Intervention on LDL Subgroups in Dyslipidemic Patients: Epidemiological Observational Study
    Ülger KAÇAR MUTLUTÜRK, Betül Çiçek, Fahrı Bayram, Fatma DOĞRUEL · 2023 · Turkish Journal of Diabetes and Obesity
  30. Atherogenesis, coronary heart disease and insulin resistance syndrome in diabetes
    Barak Zafrir, Jorge Plutzky · 2015 · Wiley eBooks
  31. Abstract and Niacin Overview
    Haseeb Jafri, Richard H. Karas, Jeffrey T. Kuvin · 2009
  32. Current World Literature
    2008 · Current Opinion in Lipidology
  33. Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis
    Zhixin Li, Ximin Hu, Yu Chen, An Li, Zaiqiu Zhang, Yán Li, Hong Yuan, Yao Lu · 2022 · SSRN Electronic Journal
  34. Comparative validation of low-density lipoprotein cholesterol estimation formulas in older Georgian adults
    Gagua Nino, Mokvanidze Lizi, Kekenadze Nino · 2025 · Practical Laboratory Medicine
  35. Age-stratified optimal non-HDL cholesterol and all-cause mortality in a healthy Taiwanese population considering personal risk factors
    Edy Kornelius, Tsuey‐Hwa Hu, Chih‐Hua Chiao, Jing‐Shiang Hwang, Ta‐Chien Chan · 2025 · International Journal of Cardiology Cardiovascular Risk and Prevention
  36. Dosage of lipoproteins for risk management according to guidelines
    Christophe Bonnin, Caroline Fourgeaud, Guillaume Mahé, Khalil Ezzaki, Marc Gras, François Xavier Himpens, Romain Jacquet, Lina Khider, Tristan Mirault, J.N. Poggi et al. · 2026 · Vascular Diseases
  37. Effect of incorporating 1 avocado per day on lipoprotein particle concentrations compared to habitual intake in adults with abdominal obesity: An ancillary study of the Habitual Diet and Avocado Trial, a randomized controlled trial
    Janhavi J Damani, Penny M. Kris‐Etherton, Nirupa Rachel Matthan, Zhaoping Li, Joan Sabaté, David M. Reboussin, Kristina S. Petersen · 2026 · Journal of clinical lipidology
  38. The Importance of LDL Particle Number in Predicting Risk of Cardiovascular Events
    Heidi H. Holmes · 2013
  39. The Acute Effect of Endurance Exercise on Lipoproteins Measured by Nuclear Magnetic Resonance (NMR) in Healthy Men
    Hanaa Adnan Shaheen · 2020